Japan’s Teijin Sues Towa Over Generic Too Similar To Teijin Drug
This article was originally published in PharmAsia News
Executive Summary
Two Japanese drug makers are involved in a legal battle over a generic maker's container design, which the suing company says was too similar to its own. Teijin Pharma filed the suit against Towa Pharmaceutical over its generic to Teijin's hay fever treatment, Rhinocort Powder Spray for Nasal Use. The suit accuses Towa of unfair competition by mimicking its packaging and method for dispensing the drug, which are too much like Teijin's. Teijin seeks an injunction and nearly $88,000 in damages. (Click here for more - a subscription may be required